Clinical Trial Update: Venlafaxine to Reduce Cocaine Dependence in Depressed Individuals [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluated venlafaxine for reducing cocaine dependence in individuals with depression. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cocaine Use Disorder
• Major Depressive Disorder

Drugs mentioned

• Venlafaxine (Venlafaxine)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Cocaine-Related Disorders | Phase 2 | Status: COMPLETED